Jones Financial Companies
AEMD icon

Jones Financial Companies’s Aethlon Medical AEMD Stock Holding History

Jones Financial Companies’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15 Buy
+3
New +$31 ﹤0.01% 4930

Other funds holding AEMD

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jones Financial Companies's AEMD Position: Q2 2026 in Review

Jones Financial Companies opened a new position in Aethlon Medical (AEMD) in Q2 2026: 3 shares worth $15. The stake represents ﹤0.01% of the portfolio and ranks #4930 among its holdings.

16 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

  • Jones Financial Companies held 3 shares of Aethlon Medical worth $15 as of Q2 2026.
  • Aethlon Medical was a new Jones Financial Companies position in Q2 2026.
  • Aethlon Medical made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4930 holding.
  • 16 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.